Michael Studnicka

5.4k total citations
66 papers, 1.3k citations indexed

About

Michael Studnicka is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiation. According to data from OpenAlex, Michael Studnicka has authored 66 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 9 papers in Radiation. Recurrent topics in Michael Studnicka's work include Lung Cancer Diagnosis and Treatment (21 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (19 papers) and Lung Cancer Treatments and Mutations (17 papers). Michael Studnicka is often cited by papers focused on Lung Cancer Diagnosis and Treatment (21 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (19 papers) and Lung Cancer Treatments and Mutations (17 papers). Michael Studnicka collaborates with scholars based in Austria, Germany and Switzerland. Michael Studnicka's co-authors include Bernhard Kaiser, Bernd Lamprecht, Sylvia Hartl, Peter Porsch, Francisco Pozo-Rodrı́guez, C Michael Roberts, José Luís López-Campos, Ady Castro-Acosta, Christian Pirich and Otto C. Burghuber and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

Michael Studnicka

61 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Studnicka Austria 17 909 294 151 147 107 66 1.3k
Lisette Nixon United Kingdom 21 1.4k 1.5× 383 1.3× 92 0.6× 123 0.8× 112 1.0× 49 1.7k
Richard J. Finley Canada 29 1.2k 1.3× 148 0.5× 36 0.2× 160 1.1× 108 1.0× 79 2.1k
Yu Ji Cho South Korea 17 416 0.5× 99 0.3× 33 0.2× 153 1.0× 115 1.1× 74 909
Wassim W. Labaki United States 18 800 0.9× 245 0.8× 42 0.3× 31 0.2× 163 1.5× 56 1.0k
Vijay Hadda India 21 825 0.9× 212 0.7× 64 0.4× 93 0.6× 72 0.7× 147 1.4k
George A. Eapen United States 32 2.3k 2.6× 263 0.9× 59 0.4× 422 2.9× 368 3.4× 100 3.3k
Yu‐Il Kim South Korea 18 703 0.8× 203 0.7× 33 0.2× 249 1.7× 121 1.1× 86 1.1k
Nathaniel Marchetti United States 22 1.1k 1.2× 322 1.1× 240 1.6× 53 0.4× 166 1.6× 82 1.6k
Lorea Martínez‐Indart Spain 19 244 0.3× 127 0.4× 24 0.2× 116 0.8× 126 1.2× 68 1.1k
Deog Kyeom Kim South Korea 22 1.1k 1.2× 450 1.5× 101 0.7× 101 0.7× 111 1.0× 150 1.7k

Countries citing papers authored by Michael Studnicka

Since Specialization
Citations

This map shows the geographic impact of Michael Studnicka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Studnicka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Studnicka more than expected).

Fields of papers citing papers by Michael Studnicka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Studnicka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Studnicka. The network helps show where Michael Studnicka may publish in the future.

Co-authorship network of co-authors of Michael Studnicka

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Studnicka. A scholar is included among the top collaborators of Michael Studnicka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Studnicka. Michael Studnicka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Studnicka, Michael, Jakub Gregor, Petra Ovesná, et al.. (2025). Hospitalisations in patients with idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry and EMPIRE Registry. ERJ Open Research. 12(1). 402–2025.
2.
Vašáková, Martina, Jakub Gregor, Nesrin Moğulkoç, et al.. (2024). Short- and long-term clinical outcomes of nintedanib therapy in IPF patients with different phenotypes: A retrospective registry-based study. Respiratory Medicine. 234. 107791–107791. 1 indexed citations
3.
Horner, Andreas, Horst Olschewski, Sylvia Hartl, et al.. (2023). Physical Activity, Depression and Quality of Life in COPD – Results from the CLARA II Study. International Journal of COPD. Volume 18. 2755–2767. 9 indexed citations
4.
Neunhäuserer, Daniel, M. Hudelmaier, David Niederseer, et al.. (2023). The Impact of Exercise Training and Supplemental Oxygen on Peripheral Muscles in Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial. Medicine & Science in Sports & Exercise. 55(12). 2123–2131. 7 indexed citations
5.
Kaiser, Bernhard, J. Karner, S. Gerum, et al.. (2022). High Dose Thoracic Re-Irradiation and Chemo-Immunotherapy for Centrally Recurrent NSCLC. Cancers. 14(3). 573–573. 6 indexed citations
6.
Welte, Tobias, Henrik Watz, Benjamin Waschki, et al.. (2020). Impact of Education on COPD Severity and All-Cause Mortality in Lifetime Never-Smokers and Longtime Ex-Smokers: Results of the COSYCONET Cohort. SHILAP Revista de lepidopterología.
7.
Horner, Andreas, Otto C. Burghuber, Sylvia Hartl, et al.. (2020). <p>Quality of Life and Limitations in Daily Life of Stable COPD Outpatients in a Real-World Setting in Austria – Results from the CLARA Project</p>. International Journal of COPD. Volume 15. 1655–1663. 15 indexed citations
8.
Vogelmeier, C. Franz, Roland Buhl, Otto C. Burghuber, et al.. (2018). Leitlinie zur Diagnostik und Therapie von Patienten mit chronisch obstruktiver Bronchitis und Lungenemphysem (COPD). Herausgegeben von der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V. und der Deutschen Atemwegsliga e. V., unter Beteiligung der Österreichischen Gesellschaft für Pneumologie. 72(4). 253–308. 1 indexed citations
9.
Hutarew, Georg, et al.. (2015). First line crizotinib in anaplastic lymphoma kinase (ALK) rearranged squamous cell lung cancer. Lung Cancer. 90(3). 614–616. 16 indexed citations
10.
11.
Lamprecht, Bernd, et al.. (2013). Endoscopic placement of fiducial markers for real-time tumor-tracking radiotherapy in 50 patients with lung cancer: A feasibility study. European Respiratory Journal. 42(Suppl 57). P2885–P2885.
12.
Lamprecht, Bernd, et al.. (2012). Electromagnetic navigation bronchoscopy (ENB): Increasing diagnostic yield. Respiratory Medicine. 106(5). 710–715. 75 indexed citations
13.
Popper, Helmut, Fritz Wrba, Ulrike Gruber-Moesenbacher, et al.. (2011). Histologie-basierter Algorithmus der molekularen Diagnostik des epidermalen Wachstumsfaktor-Rezeptorgens (Epidermal Growth Factor Receptor, EGFR) beim nicht-kleinzelligen Lungenkarzinom (non-small cell lung cancer, NSCLC)*. Wiener klinische Wochenschrift. 123(9-10). 316–321. 6 indexed citations
14.
Wurstbauer, Karl, Hannes Weise, H. Deutschmann, et al.. (2010). Non-Small Cell Lung Cancer in Stages I–IIIB. Strahlentherapie und Onkologie. 186(10). 551–557. 17 indexed citations
15.
Lamprecht, Bernd, Peter Porsch, Christian Pirich, & Michael Studnicka. (2008). Electromagnetic Navigation Bronchoscopy in Combination with PET-CT and Rapid On-site Cytopathologic Examination for Diagnosis of Peripheral Lung Lesions. Lung. 187(1). 55–59. 72 indexed citations
16.
Wurstbauer, Karl, H. Deutschmann, Peter Kopp, et al.. (2007). P3-047: NSCLC: Primary tumor size – radiation dose related accelerated, twice daily radiotherapy by target splitting, preceded by 2 cycles of chemotherapy: First results of a prospective study. Journal of Thoracic Oncology. 2(8). S626–S627. 3 indexed citations
17.
Studnicka, Michael. (2005). Epidemiology and prevention of COPD. Wiener Medizinische Wochenschrift. 155(5-6). 78–80. 2 indexed citations
18.
Hartl, Sylvia, Heinz Lahrmann, Béatrice Oberwaldner, et al.. (2004). [Provisions for long-term at home ventilated patient: consensus recommendations of the Austrian Society for Lung Diseases and Tuberculosis].. PubMed. 116 Suppl 3. 1–20. 3 indexed citations
19.
Filliger, Paul, Friedrich Horak, Jürgen E. Schneider, et al.. (2000). Public-health impact of outdoor and traffic-related air pollution: a European assessment. HAL (Le Centre pour la Communication Scientifique Directe). 1 indexed citations
20.
Studnicka, Michael, et al.. (1994). Peripheral Blood Lymphocyte Subsets and Survival in Small-Cell Lung Cancer. CHEST Journal. 105(6). 1673–1678. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lisette Nixon Breakdown of academic impact, for papers by Richard J. Finley Breakdown of academic impact, for papers by Yu Ji Cho Breakdown of academic impact, for papers by Wassim W. Labaki Breakdown of academic impact, for papers by Vijay Hadda Breakdown of academic impact, for papers by George A. Eapen Breakdown of academic impact, for papers by Yu‐Il Kim Breakdown of academic impact, for papers by Nathaniel Marchetti Breakdown of academic impact, for papers by Lorea Martínez‐Indart Breakdown of academic impact, for papers by Deog Kyeom Kim
Rankless by CCL
2026